Linda E Gustavson

Title: Linda E Gustavson: Innovator in Pharmaceutical Formulations

Introduction

Linda E Gustavson is a notable inventor in the field of pharmaceutical formulations. She is based in the United States and has made significant contributions to the development of innovative oral formulations. Although she currently holds no patents, her work has been influential in the pharmaceutical industry.

Latest Patents

Linda's latest patents include "Enteric Pharmaceutical Formulations Of Choline Salt Of Fenofibric Acid," which relates to oral formulations comprising an active agent. This active agent includes at least one of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid, its salts, or buffered forms. Another significant patent is "Extended Release Formulations Of Erythromycin Derivatives," which describes an extended release pharmaceutical composition that improves the taste profile of erythromycin derivatives compared to immediate release compositions.

Career Highlights

Linda E Gustavson is currently employed at Abbott Laboratories Corporation, where she continues to work on innovative pharmaceutical solutions. Her expertise in formulation science has contributed to the advancement of various drug delivery systems.

Collaborations

Some of her notable coworkers include Laman A Al-Razzak and Sheri L Crampton, who have collaborated with her on various projects within the pharmaceutical domain.

Conclusion

Linda E Gustavson is a dedicated inventor whose work in pharmaceutical formulations has the potential to impact patient care positively. Her contributions, although not yet reflected in patents, demonstrate her commitment to innovation in the field.